ATHE – alterity therapeutics limited - american depositary shares (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Days Volatility
Open
Prior Close

YTD

1 Day

ATHE

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/27

07:25 am

athe

Alterity Therapeutics Completes Last Patient Visit in ATH434-202 Open-Label Phase 2 Trial in Multiple System Atrophy

Low Report

Alterity Therapeutics Completes Last Patient Visit in ATH434-202 Open-Label Phase 2 Trial in Multiple System Atrophy

Report

2/10

07:25 am

athe

Alterity Therapeutics Raises A$40.0 million in Placement

Low Report

Alterity Therapeutics Raises A$40.0 million in Placement

Report

2/3

07:10 am

athe

Alterity Therapeutics Limited (NASDAQ: ATHE) was downgraded by analysts at Benchmark Co. from a "speculative buy" rating to a "hold" rating.

Medium Report

Alterity Therapeutics Limited (NASDAQ: ATHE) was downgraded by analysts at Benchmark Co. from a "speculative buy" rating to a "hold" rating.

Report

1/30

05:52 pm

athe

Alterity Therapeutics Limited (NASDAQ: ATHE) had its price target raised by analysts at Maxim Group from $8.00 to $12.00. They now have a "buy" rating on the stock.

Medium Report

Alterity Therapeutics Limited (NASDAQ: ATHE) had its price target raised by analysts at Maxim Group from $8.00 to $12.00. They now have a "buy" rating on the stock.

Report

1/30

07:35 am

athe

Alterity Therapeutics Announces Positive ATH434 Phase 2 Trial Results in Multiple System Atrophy Led By Robust Clinical Efficacy

Medium Report

Alterity Therapeutics Announces Positive ATH434 Phase 2 Trial Results in Multiple System Atrophy Led By Robust Clinical Efficacy

Report

1/24

07:35 am

athe

Appendix 4C – Q2 FY25 Quarterly Cash Flow Report

High Report

Appendix 4C – Q2 FY25 Quarterly Cash Flow Report

Report

1/9

07:25 am

athe

Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestones

Low Report

Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestones

Report

Date

Time

Symbol

Company Name

Action

%Chg

Date

Time

Action

From

Firm

Impact

%Chg

2/3

07:10 am

Downgrades

Speculative Buy

Hold

Benchmark Co.

Medium

Report

6.6%

Report

2/3

07:10 am

Downgrades

Speculative Buy

Hold

Benchmark Co.

Medium

Report

6.6%

Report

2/3

06:15 am

Downgrades

SPECULATIVE BUY

HOLD

BENCHMARK

Medium

Report

7.5%

Report

2/3

06:15 am

Downgrades

SPECULATIVE BUY

HOLD

BENCHMARK

Medium

Report

7.5%

Report

1/30

05:49 pm

Maintains

Buy

Maxim Group

Medium

Report

7.1%

Report

Date

Time

Symbol

Headline

Impact

3/27

06:13 am

athe

Form 6-K ALTERITY THERAPEUTICS For: Mar 27

Medium Report

Form 6-K ALTERITY THERAPEUTICS For: Mar 27

Report

3/25

08:00 am

athe

Form 6-K ALTERITY THERAPEUTICS For: Mar 25

Low Report

Form 6-K ALTERITY THERAPEUTICS For: Mar 25

Report

3/14

07:33 am

athe

Form 6-K ALTERITY THERAPEUTICS For: Mar 14

Medium Report

Form 6-K ALTERITY THERAPEUTICS For: Mar 14

Report

3/14

06:50 am

athe

Form 6-K ALTERITY THERAPEUTICS For: Mar 14

Medium Report

Form 6-K ALTERITY THERAPEUTICS For: Mar 14

Report

2/28

08:00 am

athe

Form 6-K ALTERITY THERAPEUTICS For: Feb 28

Low Report

Form 6-K ALTERITY THERAPEUTICS For: Feb 28

Report

2/28

07:01 am

athe

Form 6-K ALTERITY THERAPEUTICS For: Feb 28

Low Report

Form 6-K ALTERITY THERAPEUTICS For: Feb 28

Report

2/24

06:08 am

athe

Form 6-K ALTERITY THERAPEUTICS For: Feb 24

Medium Report

Form 6-K ALTERITY THERAPEUTICS For: Feb 24

Report

2/19

06:56 am

athe

Form 6-K ALTERITY THERAPEUTICS For: Feb 19

Low Report

Form 6-K ALTERITY THERAPEUTICS For: Feb 19

Report

Stock Stats

News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings

Order Stats
Sub-Penny

Odd lot

Avg. bid-ask spread

Avg. bid-ask size

Shares at ask/bid

Off exchange

Main News & Impact Reports

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.